APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Refractory Cough (CRC) Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Refractory Cough (CRC) Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025185 pages

Choose your research edition.

Industry ResearchChronic Refractory Cough (CRC) Treatment Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Refractory Cough (CRC) Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Chronic Refractory Cough (CRC) Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Refractory Cough (CRC) Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Refractory Cough (CRC) Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Chronic Refractory Cough (CRC) Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Refractory Cough (CRC) Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Refractory Cough (CRC) Treatment include Shionogi, Merck, Respivant Sciences, Nerre Therapeutics, Bellus Health and Attenua, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Chronic Refractory Cough (CRC) Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Refractory Cough (CRC) Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Refractory Cough (CRC) Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Chronic Refractory Cough (CRC) Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Refractory Cough (CRC) Treatment Segment by Company

Shionogi

Merck

Respivant Sciences

Nerre Therapeutics

Bellus Health

Attenua

Chronic Refractory Cough (CRC) Treatment Segment by Type

Speech Therapy

Physiotherapy

Chronic Refractory Cough (CRC) Treatment Segment by Application

Hospital

Clinic

Others

Chronic Refractory Cough (CRC) Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Refractory Cough (CRC) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Refractory Cough (CRC) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Refractory Cough (CRC) Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Chronic Refractory Cough (CRC) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Refractory Cough (CRC) Treatment industry.

Chapter 3: Detailed analysis of Chronic Refractory Cough (CRC) Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Refractory Cough (CRC) Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Speech Therapy Table 3. Key Players of Physiotherapy Table 4. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region (2021-2026) Table 11. Global Chronic Refractory Cough (CRC) Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region (2027-2032) Table 13. Chronic Refractory Cough (CRC) Treatment Industry Trends Table 14. Chronic Refractory Cough (CRC) Treatment Industry Drivers Table 15. Chronic Refractory Cough (CRC) Treatment Industry Opportunities and Challenges Table 16. Chronic Refractory Cough (CRC) Treatment Industry Restraints Table 17. Global Chronic Refractory Cough (CRC) Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Chronic Refractory Cough (CRC) Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Chronic Refractory Cough (CRC) Treatment Key Company Head Office and Area Served Table 21. Global Chronic Refractory Cough (CRC) Treatment Company, Product Type & Application Table 22. Global Chronic Refractory Cough (CRC) Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Chronic Refractory Cough (CRC) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2027-2032) Table 35. Shionogi Company Information Table 36. Shionogi Business Overview Table 37. Shionogi Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Shionogi Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 39. Shionogi Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 44. Merck Recent Development Table 45. Respivant Sciences Company Information Table 46. Respivant Sciences Business Overview Table 47. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 49. Respivant Sciences Recent Development Table 50. Nerre Therapeutics Company Information Table 51. Nerre Therapeutics Business Overview Table 52. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 54. Nerre Therapeutics Recent Development Table 55. Bellus Health Company Information Table 56. Bellus Health Business Overview Table 57. Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bellus Health Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 59. Bellus Health Recent Development Table 60. Attenua Company Information Table 61. Attenua Business Overview Table 62. Attenua Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Attenua Chronic Refractory Cough (CRC) Treatment Product Portfolio Table 64. Attenua Recent Development Table 65. North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026) Table 71. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032) Table 72. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026) Table 78. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032) Table 79. China Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 80. China Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 81. China Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 82. China Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026) Table 89. Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Chronic Refractory Cough (CRC) Treatment Product Image Figure 2. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Chronic Refractory Cough (CRC) Treatment Market Share by Type: 2025 VS 2032 Figure 4. Speech Therapy Image Figure 5. Physiotherapy Image Figure 6. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Chronic Refractory Cough (CRC) Treatment Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Chronic Refractory Cough (CRC) Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Chronic Refractory Cough (CRC) Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Chronic Refractory Cough (CRC) Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Chronic Refractory Cough (CRC) Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032) Figure 24. North America Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032) Figure 25. North America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032) Figure 26. United States Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032) Figure 31. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032) Figure 32. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032) Figure 33. Germany Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032) Figure 41. China Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032) Figure 42. Asia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032) Figure 44. Asia Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032) Figure 45. Asia Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032) Figure 46. Japan Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032) Figure 56. Brazil Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Speech Therapy
  • Physiotherapy
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Shionogi
  • Merck
  • Respivant Sciences
  • Nerre Therapeutics
  • Bellus Health
  • Attenua

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Speech Therapy
  5. 1.2.3 Physiotherapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Chronic Refractory Cough (CRC) Treatment Growth Trends by Region
  13. 1.5.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Chronic Refractory Cough (CRC) Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Chronic Refractory Cough (CRC) Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Chronic Refractory Cough (CRC) Treatment Market Dynamics
  1. 2.1 Chronic Refractory Cough (CRC) Treatment Industry Trends
  2. 2.2 Chronic Refractory Cough (CRC) Treatment Industry Drivers
  3. 2.3 Chronic Refractory Cough (CRC) Treatment Industry Opportunities and Challenges
  4. 2.4 Chronic Refractory Cough (CRC) Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Chronic Refractory Cough (CRC) Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Chronic Refractory Cough (CRC) Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Chronic Refractory Cough (CRC) Treatment Key Company Head office and Area Served
  4. 3.4 Global Chronic Refractory Cough (CRC) Treatment Company, Product Type & Application
  5. 3.5 Global Chronic Refractory Cough (CRC) Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Chronic Refractory Cough (CRC) Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Chronic Refractory Cough (CRC) Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Chronic Refractory Cough (CRC) Treatment Tier 1, Tier 2, and Tier 3
4 Chronic Refractory Cough (CRC) Treatment Market by Type
  1. 4.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Chronic Refractory Cough (CRC) Treatment Market Size Share by Type (2021-2032)
5 Chronic Refractory Cough (CRC) Treatment Market by Application
  1. 5.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Chronic Refractory Cough (CRC) Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Shionogi
  2. 6.1.1 Shionogi Company Information
  3. 6.1.2 Shionogi Business Overview
  4. 6.1.3 Shionogi Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Shionogi Chronic Refractory Cough (CRC) Treatment Product Portfolio
  6. 6.1.5 Shionogi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Chronic Refractory Cough (CRC) Treatment Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Respivant Sciences
  14. 6.3.1 Respivant Sciences Company Information
  15. 6.3.2 Respivant Sciences Business Overview
  16. 6.3.3 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Portfolio
  18. 6.3.5 Respivant Sciences Recent Developments
  19. 6.4 Nerre Therapeutics
  20. 6.4.1 Nerre Therapeutics Company Information
  21. 6.4.2 Nerre Therapeutics Business Overview
  22. 6.4.3 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Portfolio
  24. 6.4.5 Nerre Therapeutics Recent Developments
  25. 6.5 Bellus Health
  26. 6.5.1 Bellus Health Company Information
  27. 6.5.2 Bellus Health Business Overview
  28. 6.5.3 Bellus Health Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bellus Health Chronic Refractory Cough (CRC) Treatment Product Portfolio
  30. 6.5.5 Bellus Health Recent Developments
  31. 6.6 Attenua
  32. 6.6.1 Attenua Company Information
  33. 6.6.2 Attenua Business Overview
  34. 6.6.3 Attenua Chronic Refractory Cough (CRC) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Attenua Chronic Refractory Cough (CRC) Treatment Product Portfolio
  36. 6.6.5 Attenua Recent Developments
7 North America
  1. 7.1 North America Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
  2. 7.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type
  3. 7.2.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application
  7. 7.3.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country
  11. 7.4.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
  2. 8.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type
  3. 8.2.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application
  7. 8.3.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country
  11. 8.4.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
  2. 9.2 China Chronic Refractory Cough (CRC) Treatment Market Size by Type
  3. 9.2.1 China Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032)
  6. 9.3 China Chronic Refractory Cough (CRC) Treatment Market Size by Application
  7. 9.3.1 China Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
  2. 10.2 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Type
  3. 10.2.1 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Application
  7. 10.3.1 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country
  11. 10.4.1 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst